Since the first human experience with PSMA small molecules in 2008 with the use of Iodine-123, there has been great progress made in this space with multiple variants of small molecule PSMA inhibitors being utilized for PCa imaging. The gene discussed is FOLH1; the disease is posterior cortical atrophy.